Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

ACBBullishIndustry Newsnews

High materiality8/10

Marijuana industry taking fight against Wall Street blockades straight to Trump

Jan 9, 2026, 7:21 AM EST1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

The lobbying efforts by Pot Inc. and potential regulatory changes could boost ACB's market position, similar to past instances where legislative changes positively affected cannabis stocks.

AI summary

What happened, with direct paths to the underlying reporting

Pot Inc. aims to lobby against Wall Street's restrictions on banking cannabis. Banks argue Trump's EO doesn't empower them to serve recreational cannabis businesses. Finalizing the EO rests on Attorney General Pam Bondi, who opposes legalization. Nasdaq permits Canadian pot companies due to U.S. regulatory barriers. Marc Cohodes asserts banks misinterpret Trump's order, potentially impacting industry growth.

Pot Inc. aims to lobby against Wall Street's restrictions on banking cannabis.
Banks argue Trump's EO doesn't empower them to serve recreational cannabis businesses.
Finalizing the EO rests on Attorney General Pam Bondi, who opposes legalization.
Nasdaq permits Canadian pot companies due to U.S. regulatory barriers.
Marc Cohodes asserts banks misinterpret Trump's order, potentially impacting industry growth.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.